The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 10, 2017

Filed:

Sep. 02, 2013
Applicant:

Université DE Liège, Angleur, BE;

Inventors:

Agnès Noel, Liège, BE;

Nor Eddine Sounni, Liège, BE;

Alexandra Paye, Liège, BE;

Assignee:

UNIVERSITE DE LIEGE, Angleur, BE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); C07K 16/40 (2006.01); A61K 39/395 (2006.01); A61K 31/517 (2006.01); A61K 31/381 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C07K 16/40 (2013.01); A61K 31/381 (2013.01); A61K 31/517 (2013.01); A61K 39/39558 (2013.01); G01N 33/57484 (2013.01); C07K 2317/622 (2013.01); C07K 2317/76 (2013.01); G01N 2333/71 (2013.01); G01N 2333/912 (2013.01); G01N 2333/96486 (2013.01);
Abstract

The present invention provides MT4-MMP inhibitor and EGFR inhibitor for use in the treatment of cancer, wherein said MT4-MMP inhibitor and EGFR inhibitor are different from each other. MT4-MMP (MMP-17) is a glycosylphosphatidyl inositol (GPI) anchored MMP produced by cancer cells that promotes tumor vascularization and metastases. The present invention found that MT4-MMP expression promotes cancer cell proliferation. These effects involve retinoblastoma protein (Rb) inactivation, cyclin dependent kinase CDK4 activation and Epidermal Growth Factor Receptor (EGFR) signaling. Co-immuno-precipitations indicate the existence of protein complexes harboring MT4-MMP and EGFR. The present invention further found a novel mechanism of MT4-MMP action through an outside-in signaling involving EGFR. An unexpected crosstalk between an MMP and EGFR was identified and recognized as a key driver of cancer cell biology.


Find Patent Forward Citations

Loading…